HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes.

Cancers (Basel) · 2020 · PMC7795222 · PMID 33375706

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

We are the first to report on a highly significant association between HER2 overexpression and/or amplification and the p53abn molecular subgroup ( p < 0.0001) with 95.8% of HER2-positive EC classified in the p53abn subgroup in the PORTEC-3 HREC.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.